Retrotope's Series A - II Round

Retrotope raised a round of funding on November 01, 2012. Investors include Life Science Angels.

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope's platform prevents cellular damage and r…

Articles about Retrotope's Series A - II Round: